ArticleNature cancer2022

Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.

Yu-Yi Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.